Sunshine Biopharma (SBFM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sunshine Biopharma, Inc. recently reacquired warrants for over 21 million shares of its common stock through two separate agreements, spending a total of approximately $3.14 million. The deals involved buying back May 2023 Warrants for over $2.36 million and April 2022 Warrants at $0.08 each, adding up to $778,055. These transactions led to the cancellation and termination of the warrants, signaling a strategic move by the company to manage its outstanding securities.
For further insights into SBFM stock, check out TipRanks’ Stock Analysis page.